GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Trump Administration Said to Be Investing $500M on Developing Universal Vaccines
Earnings Scheduled For May 1, 2025
Eli Lilly Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Looking At Amgen's Recent Unusual Options Activity
Eli Lilly Stock Has The Technicals: Will Q1 Earnings Deliver Fundamentals?
SA Analyst Upgrades: PFE, ALLY, TMUS, ECC, CRK